Search Results
Jan 15, 2026, 07:00 ET BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document
More news about: Blood Profiling Atlas in Cancer (BLOODPAC) Consortium
Jan 15, 2026, 07:00 ET BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document
More news about: Blood Profiling Atlas in Cancer (BLOODPAC) Consortium
Dec 25, 2025, 04:02 ET Gene Solutions 於 ESMO Asia Congress 2025 成功舉辦 AI 驅動多組學液態活檢專題研討會，並榮獲兩項最佳海報獎
而言是成果豐碩的一年，公司在印度、土耳其、中国台灣、香港特別行政區及中國大陸的業務布局以及和合作夥伴的關係在持續擴展。Gene Solutions 开发了亞洲首項多癌早期檢測（MCED）技術推動精準腫瘤學發展，該技術已在一項涵蓋 9,024 名受試者的大型前瞻性研究中驗證，並發表於《BMC Medicine》。同時，一項涵蓋 623 名患者的真實世界循環腫瘤 DNA（ctDNA）微小殘留病灶（MRD）研究亦顯示，其在早期復發檢測方面相較於影像檢查具有更高準確性，研究成果已發表於《JCO Oncology Advances》（ASCO 出版），為更及時的臨床介入提供了有力的数据支持。專題研討會亮点：AI 驅動的液態活檢與多組學，貫穿癌症诊疗全流程
More news about: Gene Solutions Genomics Pte Ltd
Dec 25, 2025, 03:45 ET China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
C, et al. The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States. JCO Precis Oncol. 2023;7:e2200179. doi:10.1200/PO.22.00179iii.
More news about: Innovent Biologics
Dec 16, 2025, 08:00 ET Utah Cancer Specialists Partners with Canopy for Remote Therapeutic Monitoring and Enterprise AI
Large-Scale Implementation of an Electronic Patient- Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center. JCO Oncology Practice, 18(12), e1918-e1926. DOI: 10.1200/OP.22.001805 Derman, B. A., Essell, J. H., Kolodziej, M. A., Kwiatkowsky, L.,
More news about: Canopy
Dec 09, 2025, 09:00 ET LeoLabs Receives Contract from the U.S. Department of Commerce and U.S. Space Force To Jointly License Its Object Catalog for Space Safety and Security Missions
Contract leverages the nation's leading commercial source of persistent Orbital Intelligence in Low Earth Orbit to support TraCSS and JCO mission requirementsMENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/
More news about: LeoLabs, Inc.
Dec 09, 2025, 08:00 ET Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
engagement sustained at six months6 [JCO, 2022]Potential to improve
More news about: Canopy
Dec 08, 2025, 09:00 ET Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model
JAMA Network Open and JCO Clinical Cancer Informatics, showing discriminative performance with 5-year AUCs up to 0.80 across diverse screening populations in the U.S. and
More news about: Lunit
Nov 19, 2025, 09:32 ET Canopy Study Selected for Oral Presentation at ASH 2025
engagement sustained at six months5 [JCO, 2022]
More news about: Canopy
Nov 07, 2025, 17:14 ET Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS® in HER2 lung cancer
Jul;145:195-204. Presley, C. J. et al. Functional Disability Among Older Versus Younger Adults With Advanced Non–Small-Cell Lung Cancer. JCO Oncol Pract. 2021 May 3;17(6):e848–e858. Arcila, M. E. et al. Prevalence, clinicopathologic associations, and molecular spectrum
More news about: Boehringer Ingelheim
Nov 03, 2025, 09:41 ET Canopy and Willamette Valley Cancer Institute and Research Center Announce Partnership to Improve Care Between Visits
Large-Scale Implementation of an Electronic Patient- Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center. JCO Oncology Practice, 18(12), e1918-e1926. DOI: 10.1200/OP.22.001805Derman, B. A., Essell, J. H., Kolodziej, M. A., Kwiatkowsky,
More news about: Canopy
Oct 30, 2025, 10:00 ET QDCME MARKS ONE-YEAR ANNIVERSARY WITH LAUNCH OF CURATED AI AND MICROLEARNING PLATFORMS ADDRESSING ONCOLOGY AND PRIMARY CARE EDUCATIONAL NEEDS
accuracy, relevance, and patient-centered value." The launch comes at a critical time for U.S. healthcare. A recent report in JCO Oncology Practice projects a shortage of more than 2,000 oncologists by the end of 2025, a gap that is expected to grow with rising cancer
More news about: QDcme LLC
Oct 17, 2025, 10:00 ET Boehringer's HERNEXEOS® demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
Jul;145:195-204. Presley, C. J. et al. Functional Disability Among Older Versus Younger Adults With Advanced Non–Small-Cell Lung Cancer. JCO Oncol Pract. 2021 May 3;17(6):e848–e858.
More news about: Boehringer Ingelheim
Oct 09, 2025, 08:30 ET Canopy to be Highlighted at ASCO 2025 Quality Care Symposium
engagement sustained at six months3 [JCO, 2022]
More news about: Canopy